Mental Health Medication Availability in the UK

Antidepressants, anxiolytics, and psychiatric medication supply challenges
Updated 7 March 2026 from official DHSC & NHS data
Mental health medication demand in the UK has surged since 2020, with prescriptions for antidepressants increasing by over 30%. This increased demand, combined with manufacturing and supply chain challenges, has led to availability issues for several psychiatric medications.
8.6M
Antidepressant patients in England
+34%
Prescription increase since 2019
12
Psychiatric drugs affected

Current Supply Status by Category

Antidepressants (SSRIs & SNRIs)

MedicationStatusNotes
Sertraline✅ AvailableSupply recovered after 2023 shortage
Fluoxetine capsules✅ AvailableMultiple generic suppliers
Fluoxetine liquid⚠️ IntermittentLiquid formulation constrained
Citalopram✅ AvailableAdequate supply
Venlafaxine✅ AvailableMost formulations stable
Mirtazapine✅ AvailableAdequate supply
Duloxetine✅ AvailableSupply stabilised

ADHD Medications

ADHD medications remain the most significantly affected psychiatric medicines. See our dedicated ADHD shortage report for detailed status.

Anxiolytics and Sedatives

MedicationStatusNotes
Diazepam⚠️ ImprovingSome strengths limited
Pregabalin✅ AvailableMultiple suppliers
Buspirone✅ AvailableAdequate supply
Zopiclone✅ AvailableStable

Antipsychotics

MedicationStatusNotes
Quetiapine⚠️ ImprovingSome extended-release formulations constrained
Olanzapine✅ AvailableStable supply
Risperidone✅ AvailableAdequate
Aripiprazole✅ AvailableMultiple generic suppliers

Why Mental Health Medicines Face Shortages

Post-Pandemic Demand Surge

The mental health impact of COVID-19 created lasting demand increases. NHS data shows antidepressant prescriptions in England reached 86 million items in 2024-25, up from 64 million in 2018-19. This 34% increase represents millions of additional patients entering long-term treatment.

The Abrupt Cessation Risk

Mental health medication shortages are particularly concerning because many psychiatric drugs cannot be stopped abruptly:

This makes supply continuity for psychiatric medications a patient safety issue, not just an inconvenience.

What Patients Should Do

Related

Related shortages

Get free shortage alerts

Be the first to know when your medication is affected

Sign up free →
Data sources: DHSC Medicine Supply Notifications · NHSBSA Serious Shortage Protocols · NHS England
Page last updated: 7 March 2026. Data checked daily.
🏥 Data sourced from official DHSC and NHS England publications · Updated daily · Free service
MW
MediWatch Research Team
Verified against official DHSC & NHS England data

This content was researched and written by the MediWatch UK team using official government data sources. All shortage information is sourced directly from DHSC Medicine Supply Notifications and NHS England Serious Shortage Protocols. See our editorial policy and data sources for full methodology.